Eugita Therapeutics Analysis
What is Eugita Therapeutics?
Eugita Therapeutics develops tissue-targeting therapies using computational genomics and immunology to create innovative treatments for various diseases.
Company Stage
Seed
Investors
- Y Combinator
YC Batch
S22
Product Features & Capabilities
- immune cell-based therapies for breast, ovarian, and prostate cancers, focus on tissue targeting, leveraging computational genomics and immunology.
Who are the founders of Eugita Therapeutics
NB
Nizar Batada
CEO/Co-Founder
YF
Yoshi Fukazawa
VP of Research / Co-Founder
GC
George Church
Scientific Advisor / Co-Founder
Competitors Overview
Eugita Therapeutics operates in the field of tissue targeting therapies, computational genomics, and immunology. Its main competitors include:
- ArsenalBio: Focuses on curative immune cell therapies, leveraging advanced technologies to develop targeted treatments for cancer. Their advantage li
Market Focus
Eugita Therapeutics primarily focuses on the biotechnology industry, specifically in the area of tissue targeting therapies, utilizing expertise in computational genomics and immunology.
See something that needs updating? Suggest edits to this profile.